HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Qian Cheng Selected Research

Fatigue

1/2021Therapeutic Efficacy of Sorafenib in Patients with Hepatocellular Carcinoma Recurrence After Liver Transplantation: A Systematic Review and Meta-Analysis.
12/2018A pH-driven ring translocation switch against cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Qian Cheng Research Topics

Disease

76Neoplasms (Cancer)
03/2024 - 02/2010
11Inflammation (Inflammations)
07/2023 - 05/2015
10Hepatocellular Carcinoma (Hepatoma)
01/2024 - 01/2019
9Neoplasm Metastasis (Metastasis)
11/2023 - 11/2017
8Hypoxia (Hypoxemia)
01/2022 - 03/2012
7Breast Neoplasms (Breast Cancer)
04/2024 - 11/2013
6Infections
01/2023 - 01/2016
6Body Weight (Weight, Body)
10/2022 - 02/2012
5Hematologic Neoplasms (Hematological Malignancy)
11/2023 - 01/2016
5Renal Cell Carcinoma (Grawitz Tumor)
04/2023 - 10/2011
4Ischemia
07/2022 - 01/2014
4Hemorrhage
01/2022 - 06/2014
4Sepsis (Septicemia)
01/2022 - 01/2020
4Fibrosis (Cirrhosis)
01/2021 - 11/2018
4Insulin Resistance
01/2021 - 01/2015
4Multiple Myeloma
01/2020 - 01/2017
3Brain Ischemia (Cerebral Ischemia)
03/2024 - 07/2022
3Reperfusion Injury
03/2024 - 07/2022
3Leukemia
01/2024 - 01/2020
3Osteoporosis
01/2024 - 01/2017
3Pneumonia (Pneumonitis)
11/2023 - 10/2022
3Asthma (Bronchial Asthma)
08/2023 - 10/2021
3Chronic Obstructive Pulmonary Disease (COPD)
08/2023 - 02/2016
3Disease Progression
07/2023 - 01/2021
3Type 2 Diabetes Mellitus (MODY)
03/2023 - 03/2017
3Autistic Disorder (Autism)
01/2023 - 09/2017
3Autism Spectrum Disorder
01/2022 - 09/2017
3Prostatic Neoplasms (Prostate Cancer)
09/2021 - 03/2017
3Bacteremia
06/2021 - 08/2018
3Wounds and Injuries (Trauma)
01/2021 - 05/2015
3Carcinoma (Carcinomatosis)
01/2021 - 09/2014
3Lung Neoplasms (Lung Cancer)
10/2020 - 07/2013
3Necrosis
12/2019 - 12/2014
3Kidney Neoplasms (Kidney Cancer)
01/2016 - 10/2012
2Stroke (Strokes)
03/2024 - 01/2020
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2024 - 06/2023
2Shock
11/2023 - 02/2012
2Cardiovascular Diseases (Cardiovascular Disease)
11/2023 - 11/2018
2Stomach Ulcer (Gastric Ulcer)
10/2023 - 02/2022
2Alzheimer Disease (Alzheimer's Disease)
10/2023 - 11/2022
2Liver Neoplasms (Liver Cancer)
01/2023 - 03/2019
2Cholangiocarcinoma
01/2023 - 03/2022
2Atherosclerosis
10/2022 - 07/2022
2Non-Hodgkin Lymphoma (Lymphosarcoma)
10/2022 - 01/2022
2Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 01/2021
2Hyperglycemia
10/2021 - 06/2021
2Hypertension (High Blood Pressure)
10/2021 - 12/2019

Drug/Important Bio-Agent (IBA)

16Proteins (Proteins, Gene)FDA Link
01/2023 - 06/2014
9Glucose (Dextrose)FDA LinkGeneric
10/2023 - 04/2013
8Biomarkers (Surrogate Marker)IBA
04/2023 - 07/2017
8LipidsIBA
01/2023 - 01/2015
7GoldIBA
07/2023 - 02/2016
6Oxygen (Dioxygen)IBA
11/2023 - 03/2012
6AntioxidantsIBA
10/2023 - 11/2014
6MicroRNAs (MicroRNA)IBA
01/2020 - 01/2016
5RNA (Ribonucleic Acid)IBA
03/2024 - 02/2012
5Reactive Oxygen Species (Oxygen Radicals)IBA
03/2024 - 04/2013
5CytokinesIBA
07/2023 - 01/2013
5Sorafenib (BAY 43-9006)FDA Link
04/2023 - 08/2019
5Anti-Bacterial Agents (Antibiotics)IBA
12/2022 - 08/2018
5Small Interfering RNA (siRNA)IBA
01/2022 - 07/2013
4CollagenIBA
04/2023 - 09/2021
4Long Noncoding RNAIBA
01/2023 - 01/2020
4cucurbit(7)urilIBA
01/2023 - 12/2018
4AntigensIBA
10/2022 - 10/2012
4AcidsIBA
01/2022 - 09/2017
4Glutathione (Reduced Glutathione)IBA
02/2021 - 07/2018
4DNA (Deoxyribonucleic Acid)IBA
01/2021 - 04/2010
3MetalsIBA
03/2024 - 01/2020
3Immune Checkpoint InhibitorsIBA
03/2024 - 01/2020
3Ethanol (Ethyl Alcohol)IBA
01/2024 - 01/2015
3LigandsIBA
10/2023 - 01/2018
3Chimeric Antigen ReceptorsIBA
06/2023 - 01/2022
3Therapeutic UsesIBA
01/2022 - 01/2020
31-phenyl-3,3-dimethyltriazene (PDT)IBA
01/2021 - 09/2016
3naringeninIBA
01/2021 - 11/2018
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2018 - 02/2010
2HydrogelsIBA
11/2023 - 01/2023
2Superoxide DismutaseIBA
10/2023 - 04/2013
2Hyaluronic Acid (Hyaluronan)IBA
07/2023 - 07/2018
2PolyaminesIBA
01/2023 - 10/2021
2Liposomes (Liposome)IBA
01/2023 - 01/2022
2Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
01/2023 - 11/2018
2Indicators and Reagents (Reagents)IBA
11/2022 - 01/2016
2CalciumIBA
07/2022 - 07/2015
2hesperetinIBA
07/2022 - 06/2022
2SincalideFDA Link
03/2022 - 07/2015
2Silicon Dioxide (Silica)FDA LinkGeneric
02/2022 - 07/2018
2Carbapenems (Carbapenem Antibiotics)IBA
01/2022 - 06/2021
2Glucose OxidaseIBA
01/2022 - 06/2021

Therapy/Procedure

48Therapeutics
05/2024 - 02/2010
7Drug Therapy (Chemotherapy)
06/2023 - 04/2010
6Intravenous Injections
01/2023 - 10/2018
6Photothermal Therapy
02/2022 - 10/2018
5Photochemotherapy (Photodynamic Therapy)
01/2021 - 09/2016
3Precision Medicine
03/2024 - 01/2019
3Hematopoietic Stem Cell Transplantation
01/2024 - 01/2022
3Immunotherapy
01/2022 - 01/2020
3Aftercare (After-Treatment)
01/2020 - 06/2014
2Transplantation
06/2023 - 01/2023